{
    "2021-07-13": [
        [
            {
                "time": "",
                "original_text": "智飞生物参股公司细胞治疗实体瘤获突破 CD70靶点肾细胞癌获临床申请受理",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "参股公司",
                        "细胞治疗",
                        "实体瘤",
                        "CD70靶点",
                        "肾细胞癌",
                        "临床申请受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
                "features": {
                    "keywords": [
                        "2021年",
                        "医药生物",
                        "中期策略报告",
                        "需求长期景气",
                        "布局创新",
                        "医疗服务",
                        "消费主线"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "医疗服务",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}